Moderna's latest COVID-19 booster performs well against new variant
Moderna says its updated fall COVID-19 booster performed well against BA.2.86 variant.
Moderna says its updated fall COVID-19 booster performed well against BA.2.86 variant.
Moderna sued Pfizer in August, accusing it of violating its rights in three patents related to its COVID-19 vaccine.
Pfizer's animal trials showed mRNA spreads through the body, but most scientists denied the possibility of the same occurring in humans.
FDA and CDC both approve tweaked boosters, one made by Pfizer for 5- to 11-year-olds, and a Moderna version for those as young as 6.
Moderna claims that Pfizer and BioNTech copied its formula for the COVID-19 vaccine.
British regulators are the first in the world to authorize updated version of Moderna's vaccine that aims to protect against Omicron.
New study shows over 8 per 10,000 net increase in hospitalization following vaccination.
Moderna says its new "bivalent" vaccine performed well against Omicron's latest subvariants.
Food and Drug Administration authorizes Pfizer and Moderna shots for children under 5. Vaccinations could begin next week.
Food and Drug Administration's vaccine advisers approve Moderna and Pfizer’s COVID-19 vaccine for infants, toddlers and preschoolers.
Announcement comes almost a year after several European countries limited use of vaccine.
Trial results from a month following injection show 8-fold increase in antibodies.
Moderna officials say the new vaccine will undergo thorough testing before being administered to children.
Moderna asks FDA to authorize fourth shot of its COVID-19 vaccine as booster dose for all adults.
CEO of Moderna says firm is still gathering clinical data on Omicron-specific booster.
Moderna vaccine becomes 2nd COVID vaccine to be fully approved for adults by the FDA, about 1/2 year after the Pfizer vaccine was approved.
Moderna says first participant has been dosed in Phase 2 clinical trial of COVID-19 booster shot that is specific to Omicron variant.
Data shows Moderna booster shot increases neutralizing antibodies against the omicron variant.
CDC panel votes to give preferential recommendation to vaccines like Pfizer and Moderna over Johnson & Johnson due to blood clots.
Dr. Burton warns of "situation where individuals will become co-infected" with both Delta & Omicron, leading to more mutations emerging.
Stéphane Bancel stressed risks involved in switching production to Omicron-focused vaccine, suggested booster doses were a better option.
Moderna applies with Food and Drug Administration for authorization of its COVID-19 booster vaccine for all adults aged 18 and older.
FDA says it will require additional time to complete its assessment of Moderna's COVID-19 vaccine for use in adolescents.
Moderna says a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, will share results with FDA.
CDC also approves mixing and matching of any of the three vaccines approved for use in the US.
Regulator also approves “mix and match” method, allows people to choose different shot than their original inoculation as a booster.
FDA delaying decision on authorizing Moderna's COVID-19 vaccine for adolescents.
Panel of expert advisers to FDA votes 19-0 to recommend booster shots of Moderna's COVID-19 vaccine for Americans aged 65 and older.
Scientists at FDA say Moderna has not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine.
Independent advisers to CDC will meet later this month to make recommendations on booster doses of Moderna and Johnson & Johnson's vaccines.
Scandinavian countries reduce use of Moderna vaccine following study showing increased risk of heart inflammation.
European Medicines Agency approves 3rd doses of Pfizer, Moderna vaccines for all adults 6 months after 2nd shot.
After heading Moderna's coronavirus vaccine development, Dr. Tal Zaks is ready to tackle new challenges at Israel's Teva Pharmaceuticals.
Moderna Chief Executive says enough vaccine doses should be available by the middle of next year so that everyone can be vaccinated.
Moderna says it is developing a single vaccine that combines a booster dose against COVID-19 and the flu.
Japan's health ministry says contaminants found in suspended Moderna COVID-19 shots were particles of stainless steel.
US Secretary of State Antony Blinken announces Biden Administration to ship 500,000 vaccine doses to PA. 'We are pleased to help lives.'
UK's health regulator approves Moderna's COVID-19 vaccine for use in children aged 12 to 17 years.
Moderna vaccine remains 93% effective six months after second dose, company says.
European Medicines Agency recommends authorizing Moderna’s COVID-19 vaccine for children ages 12 to 17.